Lifeboat Foundation

Canadian firm says it could make 10 million doses per month — if its innovative production method wins FDA approval.

A Canadian company says that it has produced a COVID −19 vaccine just 20 days after receiving the coronavirus’s genetic sequence, using a unique technology that they soon hope to submit for FDA approval.

Medicago CEO Bruce Clark said his company could produce as many as 10 million doses a month. If regulatory hurdles can be cleared, he said in a Thursday interview, the vaccine could start to become available in November 2021.

The Japan Maritime Self Defense Force’s latest diesel-electric attack submarine was commissioned on March 5.

By Franz-Stefan Gady for The Diplomat.

Lasers o.o

They could supply energy to far-flung bases, power laser weapons and charge electric vehicles.

Science and technology Mar 14th 2020 edition.

Continue reading “Nuclear power plants are coming to the battlefield” »

Specializes in the sale of government and military-grade gas mask and protective clothing. Now offering Pet Safe : provides an excellent protection shield for dogs, cats or other animals against NBC weapons using the same principal as a gas mask or protective enclosure.

A sharp-eyed satellite’s launch has been pushed back from its expected Thursday (March 5) launch date until no earlier than April due to a rocket problem, according to a media report.

Arianespace, which will be providing the launch from French Guiana, has not disclosed a reason for the delay. Nor did it release a new launch date for Falcon Eye 2, which is a high-performance optical observation satellite for commercial and military users in the United Arab Emirates.

Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care.

The online version of this article (doi:10.1007/s13311-011‑0097-2) contains supplementary material, which is available to authorized users.

Keywords: Neuroterrorism, Bioterrorism, Warfare Agents.

Phase 3 of DARPA’s Operational Fires (OpFires) program began in earnest this month with government and contractor staff finalizing the system architecture approach, including a plan to use existing components from ground-launched missile systems, along with new booster technologies designed to support future hypersonic weapons. Lockheed Martin Missiles and Fire Control is leading the integration effort for the third phase of the program, which will focus on first stage booster design and maturation, launcher development, and vehicle integration.

Broad participation from the Army’s Combat Capabilities Development Command, range safety offices, and performers from OpFires Phase 2 propulsion teams contributed to success in the early, critical stages of the program. Since 2018, OpFires has made impressive strides developing and demonstrating advanced booster technologies that had never been used in prior systems. Phase 1 and 2 performers Aerojet Rocketdyne, Exquadrum, and Sierra Nevada Corporation continue work towards throttle-able upper stage rocket motors suitable for tactical transport, storage, and engagement.

“The objective of DARPA’s OpFires program is to deliver an intermediate-range surface-to-surface missile in line with the Department of Defense’s push to field hypersonic platforms,” said MAJ Amber Walker (USA), the DARPA program manager for OpFires.

Is it so outlandish to believe that countries in the future might resort to military force to prevent other countries from altering the shared genetic code of humanity? Many countries have been invaded for far less.

The genetics revolution that will transform our health care, the way we make babies, the nature of the babies we make, and ultimately our evolutionary trajectory as a species has already begun. Just like parents in many places will need to make tough choices about whether, if at all, to genetically engineer their children, states will be forced to make monumental collective decisions on these issues with potentially fateful consequences.

Continue reading “The designer baby debate could start a war” »

The scientific revolution was ushered in at the beginning of the 17th century with the development of two of the most important inventions in history — the telescope and the microscope. With the telescope, Galileo turned his attention skyward, and advances in optics led Robert Hooke and Antonie van Leeuwenhoek toward the first use of the compound microscope as a scientific instrument, circa 1665. Today, we are witnessing an information technology-era revolution in microscopy, supercharged by deep learning algorithms that have propelled artificial intelligence to transform industry after industry.

One of the major breakthroughs in deep learning came in 2012, when the performance superiority of a deep convolutional neural network combined with GPUs for image classification was revealed by Hinton and colleagues [1] for the ImageNet Large Scale Visual Recognition Challenge (ILSVRC). In AI’s current innovation and implementation phase, deep learning algorithms are propelling nearly all computer vision-intensive applications, including autonomous vehicles (transportation, military), facial recognition (retail, IT, communications, finance), biomedical imaging (healthcare), autonomous weapons and targeting systems (military), and automation and robotics (military, manufacturing, heavy industry, retail).

It should come as no surprise that the field of microscopy would ripe for transformation by artificial intelligence-aided image processing, analysis and interpretation. In biological research, microscopy generates prodigious amounts of image data; a single experiment with a transmission electron microscope can generate a data set containing over 100 terabytes worth of images [2]. The myriad of instruments and image processing techniques available today can resolve structures ranging in size across nearly 10 orders of magnitude, from single molecules to entire organisms, and capture spatial (3D) as well as temporal (4D) dynamics on time scales of femtoseconds to seconds.